Literature DB >> 16061523

Migraine: new molecular mechanisms.

Daniela Pietrobon1.   

Abstract

Migraine is an episodic headache disorder affecting more than 10% of the general population. Migraine arises from a primary brain dysfunction that leads to activation and sensitization of the trigeminovascular system. A major incompletely understood issue in the neurobiology of migraine concerns the molecular and cellular mechanisms that underlie the primary brain dysfunction and lead to activation and sensitization of the trigeminovascular system, thus generating and maintaining migraine pain. Here the author reviews recent discoveries that have advanced our understanding of these mechanisms toward a unifying pathophysiological hypothesis, in which cortical spreading depression (CSD), the phenomenon underlying migraine aura, assumes a key role. In particular, the author discusses the main recent findings in the genetics and neurobiology of familial hemiplegic migraine and the insights they provide into the molecular and cellular mechanisms that may lead to the increased susceptibility of CSD in migraineurs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16061523     DOI: 10.1177/1073858405275554

Source DB:  PubMed          Journal:  Neuroscientist        ISSN: 1073-8584            Impact factor:   7.519


  58 in total

Review 1.  Headache-type adverse effects of NO donors: vasodilation and beyond.

Authors:  G Bagdy; P Riba; V Kecskeméti; D Chase; G Juhász
Journal:  Br J Pharmacol       Date:  2010-03-19       Impact factor: 8.739

2.  Invited Lectures : Overviews Purinergic signalling: past, present and future.

Authors: 
Journal:  Purinergic Signal       Date:  2006-05-15       Impact factor: 3.765

Review 3.  Inhibition of calcitonin gene-related peptide function: a promising strategy for treating migraine.

Authors:  Paul L Durham
Journal:  Headache       Date:  2008-09       Impact factor: 5.887

Review 4.  Calcium channels and synaptic transmission in familial hemiplegic migraine type 1 animal models.

Authors:  Osvaldo D Uchitel; Carlota González Inchauspe; Mariano N Di Guilmi
Journal:  Biophys Rev       Date:  2013-12-03

5.  Whole isolated neocortical and hippocampal preparations and their use in imaging studies.

Authors:  Melissa L Davies; Sergei A Kirov; R David Andrew
Journal:  J Neurosci Methods       Date:  2007-07-25       Impact factor: 2.390

Review 6.  The cerebellum and migraine.

Authors:  Maurice Vincent; Nouchine Hadjikhani
Journal:  Headache       Date:  2007-06       Impact factor: 5.887

7.  Two mechanisms involved in trigeminal CGRP release: implications for migraine treatment.

Authors:  Paul L Durham; Caleb G Masterson
Journal:  Headache       Date:  2012-10-23       Impact factor: 5.887

Review 8.  Regulation of voltage-gated calcium channels by proteolysis.

Authors:  Kathryn Abele; Jian Yang
Journal:  Sheng Li Xue Bao       Date:  2012-10-25

9.  Vitamin D in migraine headache: a comprehensive review on literature.

Authors:  Zeinab Ghorbani; Mansoureh Togha; Pegah Rafiee; Zeynab Sadat Ahmadi; Reyhaneh Rasekh Magham; Samane Haghighi; Soodeh Razeghi Jahromi; Maryam Mahmoudi
Journal:  Neurol Sci       Date:  2019-08-03       Impact factor: 3.307

10.  Shared genetic factors in migraine and depression: evidence from a genetic isolate.

Authors:  A H Stam; B de Vries; A C J W Janssens; K R J Vanmolkot; Y S Aulchenko; P Henneman; B A Oostra; R R Frants; A M J M van den Maagdenberg; M D Ferrari; C M van Duijn; G M Terwindt
Journal:  Neurology       Date:  2010-01-13       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.